Assessing Retinal Structure in Patients with Parkinson's Disease

Area of Science:

• Ophthalmology
• Neuroscience
• Biomarker Discovery

Background:

• The retina, an extension of the central nervous system (CNS), may serve as a biomarker for neurodegenerative diseases like Parkinson's disease (PD).
• Dopaminergic cells in the retina are implicated in PD, making retinal structure a potential indicator of disease progression.

Purpose of the Study:

• To evaluate retinal structure, specifically foveal pit morphology and thickness, in patients diagnosed with Parkinson's disease (PD).
• To explore the potential of retinal anatomical features as accessible biomarkers for monitoring PD progression.

Main Methods:

• Spectral-domain optical coherence tomography (SD-OCT) was used for retinal imaging in 33 PD patients and 40 controls.
• Axial length measurements corrected the lateral scale of macular scans for precise foveal morphology and retinal thickness quantification.
• A logistic regression model incorporating sex and corrected ETDRS regions was used to predict PD.

Main Results:

• Foveal morphology measurements demonstrated high interocular symmetry in both PD patients and control subjects.
• No significant differences in foveal pit morphology were observed between the two groups.
• A predictive model using sex and specific retinal thickness regions achieved a C-statistic of 0.80.

Conclusions:

• PD patients maintain foveal symmetry between eyes, and retinal thickness measurements, when properly scaled, can be valuable.
• Sex and specific retinal regions (center 1 mm and temporal outer ETDRS) were significant predictors of PD.
• Future PD predictive models using OCT should consider gender and racial variations in retinal anatomy.